Related Experiment Video
Updated: Jun 5, 2025

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
Maduramicin ammonium impairs autophagic flux through activating AMPK-mediated eIF2α-ATF4 endoplasmic reticulum stress
Xin Chen1,2,3, Xin Xie1, Chang Liu1
1Laboratory of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
Background:
Maduramicin ammonium (MA), a widely used coccidiostat, has been reported to cause skeletal muscle degeneration in animals and even humans. In this study, we explore the underlying mechanism of its toxicity in skeletal muscle.
Results:
First, we observed that MA impaired autophagic flux which was evidenced by increased protein level of LC3-II and p62 in skeletal myoblast C2C12 and L6 cell lines and rectus femoris muscle tissues of rats and broilers. Then, we found that MA induced eIF2α phosphorylation and ATF4 expression in the cells and tissues. Co-treatment with ISRIB attenuated MA-induced LC3-II and p62 in C2C12 and L6 cells, suggesting that MA-induced eIF2α-ATF4 pathway contributed to impairment of autophagic flux in the cells. Lastly, we showed that MA activated AMPK signaling in skeletal muscle, since the phosphorylation of AMPK was increased by MA treatment in skeletal myoblast cell lines and muscle tissues. Furthermore, in AMPK downregulated C2C12 cells, MA-induced LC3-II, ATF4 and phosphorylation of eIF2α was reversed, supporting that AMPK was involved in the regulation of the eIF2α-ATF4 pathway and autophagic flux during MA exposure.
Conclusion:
Our findings showed that MA impairs autophagic flux through activating the AMPK-induced eIF2α-ATF4 pathway in skeletal muscle. © 2024 Society of Chemical Industry.
Insights
Maduramicin ammonium impairs skeletal muscle autophagic flux by activating the AMPK-induced eIF2α-ATF4 pathway. This research clarifies the mechanism behind maduramicin ammonium toxicity in muscle tissue.
Area of Science:
- Biochemistry
- Cell Biology
- Toxicology
Background:
- Maduramicin ammonium (MA) is a coccidiostat linked to skeletal muscle degeneration.
- Understanding MA's toxicity mechanism in muscle is crucial.
Purpose of the Study:
- To investigate the molecular mechanisms underlying maduramicin ammonium-induced skeletal muscle toxicity.
- To elucidate the role of autophagic flux and specific signaling pathways.
Main Methods:
- Assessed autophagic flux markers (LC3-II, p62) in skeletal myoblast cell lines (C2C12, L6) and animal tissues.
- Examined eIF2α phosphorylation and ATF4 expression.
- Investigated the involvement of the AMPK signaling pathway and ISRIB co-treatment.
Main Results:
- MA exposure increased LC3-II and p62, indicating impaired autophagic flux.
- MA induced eIF2α phosphorylation and ATF4 expression, which was partially reversed by ISRIB.
- MA activated AMPK signaling, and its downregulation reversed MA-induced effects on autophagic flux and the eIF2α-ATF4 pathway.
Conclusions:
- Maduramicin ammonium impairs skeletal muscle autophagic flux.
- This impairment is mediated by the activation of the AMPK-induced eIF2α-ATF4 pathway.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Unfolded Protein Response
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Export of Misfolded Proteins out of the ER

